Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Increasing incidence of cancer is expected to propel growth of the global biopsy devices market over the forecast period. For instance, in 2021, an estimated 281,550 new cases of invasive breast cancer are expected to be diagnosed in women, along with 49,290 new cases of non-invasive (in situ) breast cancer. Moreover, approval and launch of new products is also expected to aid in growth of the market. For instance, in October 2021, Quanterix Corporation received Breakthrough Device designation from the U.S. Food and Drug Administration for its Simoa phospho-Tau 181 (pTau-181) blood test as an aid in diagnostic evaluation of Alzheimer’s disease.
Increasing investment in R&D of liquid biopsy is expected to offer lucrative growth opportunities for players in the global liquid biopsy market. For instance, in March 2020, BillionToOne, Inc. raised US$ 15 million to support the commercial expansion of UNITY, a prenatal screen that directly assesses the baby’s risk for common and severe inherited disorders.
Major players in the global liquid biopsy market are focused on approval and launch of new devices in order to expand their product portfolio. For instance, in January 2020, Zomedica Pharmaceuticals Corp., a veterinary diagnostic and pharmaceutical company, announced completing the development and manufacturing of its reference lab cancer liquid biopsy platform for canine cancers.
Major players in the market are also focused on adopting partnership and collaboration strategies in order to enhance their market share. For instance, in October 2021, Caris Life Sciences, a molecular science company, partnered with ESSA Pharma Inc., a clinical-stage pharmaceutical company, for liquid biopsy profiling to assess genetic profiles utilizing Caris' Whole Transcriptome Sequencing and Whole Exome Sequencing platform.
Key Takeaways
- Increasing incidence of cancer is expected to propel growth of the global biopsy devices market over the forecast period
- Major players in the market are focused on adopting partnership and collaboration strategies in order to enhance their market share. For instance, in February 2020, Foundation Medicine, Inc. and Chugai Pharmaceutical, Ltd. collaborated with National Cancer Center (NCC) for the use of FoundationOneLiquid, Foundation Medicine’s laboratory-developed liquid biopsy test, in the third stage of SCRUM-Japan, a cancer genomic screening consortium in Japan.
- Major players operating in the global liquid biopsy market include, Illumina, Inc., Roche AG, Natera, Inc., Laboratory Corporation of America Holdings (LabCorp), Qiagen N.V., Thermo Fisher Scientific Inc., Exact Sciences Corp., Biocept, Inc., Genomic Health, Inc., Guardant Health, TrovaGene Inc., CareDx Inc., Adaptive Biotechnologies Corporation, and Biocartis SA.
Key features of the study:
- This report provides in-depth analysis of liquid biopsy market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global liquid biopsy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key companies covered as a part of this study include Illumina, Inc., Roche AG, Natera, Inc., Laboratory Corporation of America Holdings (LabCorp), Qiagen N.V., Thermo Fisher Scientific Inc., Exact Sciences Corp., Biocept, Inc., Genomic Health, Inc., Guardant Health, TrovaGene Inc., CareDx Inc., Adaptive Biotechnologies Corporation, and Biocartis SA.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global liquid biopsy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the liquid biopsy market
Detailed Segmentation:
Global Liquid Biopsy Market, By Products & Services:
Reagents & Kits
Equipments
Services
Global Liquid Biopsy Market, By Sample:
Cell Free DNA (cfDNA)
Circulating Tumor Cells (CTC)
Exosomes
Global Liquid Biopsy Market, By Application:
Oncology Testing
Noninvasive Prenatal Testing
Transplant Care
Global Liquid Biopsy Market, By End User:
Hospitals
Research Laboratories
Diagnostic Laboratories
Patients
Global Liquid Biopsy Market, By Geography:
North America
By Product & Services:
Reagents & Kits
Equipments
Services
By Sample:
Cell Free DNA (cfDNA)
Circulating Tumor Cells (CTC)
Exosomes
By Application:
Oncology Testing
Noninvasive Prenatal Testing
Transplant Care
By End User:
Hospitals
Research Laboratories
Diagnostic Laboratories
Patients
By Country:
U.S.
Canada
Europe
By Product & Services:
Reagents & Kits
Equipments
Services
By Sample:
Cell Free DNA (cfDNA)
Circulating Tumor Cells (CTC)
Exosomes
By Application:
Oncology Testing
Noninvasive Prenatal Testing
Transplant Care
By End User:
Hospitals
Research Laboratories
Diagnostic Laboratories
Patients
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Product & Services:
Reagents & Kits
Equipments
Services
By Sample:
Cell Free DNA (cfDNA)
Circulating Tumor Cells (CTC)
Exosomes
By Application:
Oncology Testing
Noninvasive Prenatal Testing
Transplant Care
By End User:
Hospitals
Research Laboratories
Diagnostic Laboratories
Patients
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Product & Services:
Reagents & Kits
Equipments
Services
By Sample:
Cell Free DNA (cfDNA)
Circulating Tumor Cells (CTC)
Exosomes
By Application:
Oncology Testing
Noninvasive Prenatal Testing
Transplant Care
By End User:
Hospitals
Research Laboratories
Diagnostic Laboratories
Patients
By Country:
Brazil
Mexico
Rest of Latin America
Middle East
By Product & Services:
Reagents & Kits
Equipments
Services
By Sample:
Cell Free DNA (cfDNA)
Circulating Tumor Cells (CTC)
Exosomes
By Application:
Oncology Testing
Noninvasive Prenatal Testing
Transplant Care
By End User:
Hospitals
Research Laboratories
Diagnostic Laboratories
Patients
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product & Services:
Reagents & Kits
Equipments
Services
By Sample:
Cell Free DNA (cfDNA)
Circulating Tumor Cells (CTC)
Exosomes
By Application:
Oncology Testing
Noninvasive Prenatal Testing
Transplant Care
By End User:
Hospitals
Research Laboratories
Diagnostic Laboratories
Patients
By Country:
Central Africa
South Africa
North Africa
Company Profiles
Roche AG *
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Illumina, Inc.
Natera Inc.
Laboratory Corporation of America Holdings
Qiagen N.V.
Thermo Fisher Scientific
Exact Sciences Corp.
Biocept, Inc.
Genomic Health, Inc.
Guardant Health
CareDx Inc.
Adaptive Biotechnologies Corporation
Biocartis SA.
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
? Market Definition and Scope
o Executive Summary
? Market Snippet, By Products & Services
? Market Snippet, By Sample
? Market Snippet, By Application
? Market Snippet, By End User
? Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
? Drivers
? Restraints
? Market Opportunities
o PEST Analysis
o Porter's Five Forces Analysis
o Regulatory Scenario
o Technological Evolution
o Mergers & Acquisition
o Pipeline Analysis
o Recently Launched Products
4. Global Liquid Biopsy Market, By Products & Services, 2017-2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017-2025
? Segment Trends
o Reagents & Kits
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
o Equipments
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
o Services
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
5. Global Liquid Biopsy Market, By Sample, 2017-2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017-2025
? Segment Trends
o Cell Free DNA (cfDNA)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
o Circulating Tumor Cells (CTC)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
o Exosomes
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
6. Global Liquid Biopsy Market, By Application, 2017-2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017-2025
? Segment Trends
o Oncology Testing
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
o Noninvasive Prenatal Testing (NIPT)
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
o Transplant Care
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
7. Global Liquid Biopsy Market, By End User, 2017-2025 (US$ Mn)
o Introduction
? Market Share Analysis, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, 2017-2025
? Segment Trends
o Hospitals
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
o Research Laboratories
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
o Diagnostic Laboratories
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
o Patients
? Introduction
? Market Size and Forecast, and Y-o-Y Growth, 2017-2025, (US$ Mn)
8. Global Liquid Biopsy Market, By Regions, 2017-2025 (US$ Mn)
o Introduction
? Market Share Analysis, By Region, 2016 and 2025 (%)
? Y-o-Y Growth Analysis, For Regions, 2017-2025
o North America
? Market Size and Forecast, By Products & Services, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Sample, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2017-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? U.S.
? Canada
o Europe
? Market Size and Forecast, By Products & Services, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Sample, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2017-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? U.K.
? Germany
? Italy
? France
? Spain
? Russia
? Rest of Europe
o Asia Pacific
? Market Size and Forecast, By Products & Services, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Sample, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2017-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? China
? India
? Japan
? ASEAN
? Australia
? South Korea
? Rest of APAC
o Latin America
? Market Size and Forecast, By Products & Services, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Sample, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2017-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? Brazil
? Mexico
? Rest of Latin America
o Africa
? Market Size and Forecast, By Products & Services, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Sample, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2017-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? Central Africa
? South Africa
? North Africa
o Middle East
? Market Size and Forecast, By Products & Services, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Sample, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Application, 2017-2025 (US$ Mn)
? Market Size and Forecast, By End User, 2017-2025 (US$ Mn)
? Market Size and Forecast, By Country, 2017-2025 (US$ Mn)
? GCC
? Israel
? Rest of Middle East
9. Competitive Landscape
o Heat Map Analysis
o Company Profiles
? Roche AG
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Illumina, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Natera Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Laboratory Corporation of America Holding
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Qiagen N.V.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Thermo Fisher Scientific
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Exact Sciences Corp.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Biocept, Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Genomic Health Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Guardant Health
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? CareDx Inc.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Adaptive Biotechnologies Corporatio
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
? Biocartis SA.
? Company Overview
? Product Portfolio
? Key Developments
? Financial Performance
? Strategies
10. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 48 market data tables and 57 figures on "Liquid Biopsy Market - Global forecast to 2025".
